Search

everythinglearnresearchcommunity

for

Search:↓

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Men with male pattern baldness may have a higher risk of heart problems.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Women with irregular periods have a higher risk of heart disease.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.